Article info

Download PDFPDF
Cost effectiveness study
Cardiac resynchronisation therapy with an implantable cardioverter defibrillator appears to be cost-effective in patients with mild heart failure

Authors

  1. Correspondence to : Dr Keith Cooper, University of Southampton, SHTAC, Epsilon House, Enterprise Road, Southampton, SO16 7NS, UK; kc{at}soton.ac.uk
View Full Text

Citation

Cooper K
Cardiac resynchronisation therapy with an implantable cardioverter defibrillator appears to be cost-effective in patients with mild heart failure

Publication history

  • First published February 17, 2016.
Online issue publication 
May 23, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.